Senolytics: Scientists identify new class of drugs that slows the aging process

From the Independent:

“A new class of drugs has been identified that slow the ageing process in mice, alleviating symptoms of frailty and extending a healthy lifespan.

If their effect on humans is as marked as it is on animal models, their benefit could be enormous.

The research was carried out by a team from Mayo Clinic, The Scripps Institute and other institutions and published in the journal Aging Cell yesterday.

“We view this study as a big, first step toward developing treatments that can be given safely to patients to extend healthspan or to treat age-related diseases and disorders,” said co-lead author and TSRI Professor Paul Robbins, PhD.”